Vaccination against malaria with live parasites (Q36600336)

15 August 2017

1 reference

title

Vaccination against malaria with live parasites (English)

1 reference

15 August 2017

0 references

4

1 reference

15 August 2017

1

Laurent Rénia

1 reference

PubMed ID

16989628

15 August 2017

Anne Charlotte Grüner

series ordinal

2

object named as

Anne Charlotte Grüner

1 reference

15 August 2017

3

Marjorie Mauduit

1 reference

15 August 2017

1 August 2006

1 reference

Expert Review of Vaccines

15 August 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 August 2017

5

1 reference

15 August 2017

4

1 reference

15 August 2017

473-481

1 reference

The pathogenic basis of malaria

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

The generation of genetic diversity in malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Gamma-globulin and acquired immunity to human malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Progress and challenges for malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Efficacy trial of malaria vaccine SPf66 in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

The Plasmodium sporozoite survives RTS,S vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Live vaccine against hemoparasitic disease in livestock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Poultry coccidiosis: recent advancements in control measures and vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

The complexity of protective immunity against liver-stage malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Protection against malaria induced by irradiated sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuatedPlasmodium falciparumsporozoite vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Resistance produced in rats and mice by exposure to irradiated Plasmodium berghei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Plasmodium berghei: isolation and maintenance of an irradiation attenuated strain in the nude mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Plasmodium yoelii: induction of attenuated mutants by irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Genetically modified Plasmodium parasites as a protective experimental malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Plasmodium berghei: Immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

Specificity of Protective Immunity produced by X-irradiated Plasmodium berghei Sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.473

21 January 2018

Identifiers

DOI

10.1586/14760584.5.4.473

1 reference

15 August 2017

1 reference

PubMed ID

16989628